To assess if PpIX and BPD inhibit TrxR activity in cancer cells also, we treated Panc1 cells with the increasing concentrations of PpIX or BPD for 6 h and assayed the activity using the end point Trx-dependent insulin-reduction assay. The gene discussed is INS; the disease is cancer.